Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNA topoisomerase 1–DNA cleavable complex (Top1cc) is a transient catalytic intermediate formed when the enzyme DNA topoisomerase 1 (Top1) nicks a single strand of DNA to relieve torsional strain during replication and transcription (Pommier, Nat Rev Cancer, 2006; Champoux, Annu Rev Biochem, 2001). In this state, the enzyme is covalently linked to the 3' phosphate end of the DNA via a tyrosyl-DNA phosphodiester bond (Pommier et al., Chem Rev, 2016). This complex is the primary molecular target for camptothecin-derived chemotherapeutic agents, which act as interfacial inhibitors by binding at the site of the DNA cleavage (Pommier, Nat Rev Cancer, 2006). By stabilizing the Top1cc, these drugs prevent the religation of the DNA strand, effectively trapping the enzyme on the DNA (Pommier et al., Chem Rev, 2016). When advancing replication forks or transcription complexes collide with these trapped Top1ccs, they are converted into lethal double-strand breaks, triggering apoptosis (Thomas et al., Clin Cancer Res, 2017). This mechanism makes Top1cc a critical target in the treatment of various malignancies, including colorectal and small cell lung cancers (Pommier, Nat Rev Cancer, 2006).
Stabilization of the transient covalent Top1-DNA complex, inhibiting DNA religation and causing replication-mediated DNA damage.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA topoisomerase 1–DNA cleavable complex (Top1cc) (Top1cc).